Two insiders at Jazz Pharmaceuticals plc (JAZZ) sold shares totaling approximately $12.31 million on November 10, 2026. Bruce C. Cozadd, a Director, executed two transactions, selling 27,714 shares at an average price of $234.91 per share, valued at $6.51 million, and an additional 24,483 shares at an average price of $236.84 per share, totaling $5.80 million.
These transactions follow a series of sales by Mr. Cozadd reported on November 6, 2026, and a smaller sale by Patricia Carr on November 4, 2026. While insider selling can occur for various reasons, including portfolio diversification or personal financial needs, multiple sales by company insiders can sometimes draw investor attention.